Emergent BioSolutions Inc. provides a variety of products and solutions that address public health threats, including manufacturing for the development of new vaccines. In April 2020, during the initial months of the COVID-19 pandemic, Emergent entered an agreement with J&J to provide its Bayview manufacturing facilities to support J&J’s goal of supplying one billion doses of a COVID-19 vaccine. Under the deal, valued at $135 million, Emergent would provide drug substance manufacturing services and reserve large-scale manufacturing capacity for J&J.
Recent Security Class Actions
Arcimoto Inc. is purportedly engaged in the business of manufacturing ultraefficient three-wheeled electric vehicles.
Acadia Pharmaceuticals Inc. is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The Company is developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia, as well as an adjunctive treatment for major depressive disorder. In June 2020, Acadia submitted a supplemental New Drug Application ("sNDA") with the FDA to expand pimavanserin's label to include treatment for dementia-related psychosis.
Churchill Capital Corporation IV is a blank check company, also known as a special purpose acquisition company (“SPAC”). On Monday, February 22, 2021, a merger agreement between Churchill Capital Corporation IV ("CCIV") and Lucid Motors was announced. CCIV’s and Lucid’s transaction equity value was estimated at $11.75 billion. Details of the merger disclosed that Lucid was projecting the production of only 557 vehicles in 2021, instead of the 6,000 it had allegedly been touting in the run-up to the merger announcement.
LifeMD, Inc. is a direct-to-patient telehealth company. It offers a telemedicine platform that purports to help patients access licensed providers for diagnoses, virtual care, and prescription medications. LifeMD was previously known as Conversion Labs, Inc., and its common stock traded on the NASDAQ exchange under the symbol “CVLB.” The Company’s name was changed effective February 19, 2021, and the stock symbol changed effective February 22, 2021.
On January 27, 2021, Perspecta announced its entry into an Agreement and Plan of Merger pursuant to which it would be sold to Veritas Capital.
Intrusion Inc. develops, sells, and supports products that purport to protect entities from cyberattacks by combining advanced threat intelligence with real-time artificial intelligence. It offers three products: Shield, a cybersecurity solution packaged as a comprehensive, real-time AIbased Security-as-a-Service; TraceCop, a big data tool with IP intelligence, including reputation information on known good and known bad active IP addresses; and Savant, a network monitoring solution that identifies suspicious traffic in real-time.
Franklin Wireless Corp. purports to be a leading provider of intelligent wireless solutions such as mobile hotspots, routers, trackers, and other devices.
Credit Suisse Group AG is a global financial services company.
On October 5, 2020, RMG Acquisition Corp. (“RMG”) announced a definitive agreement for a business combination with Romeo Power Inc. that would result in Romeo becoming a publicly listed company. On December 29, 2020, Romeo announced that it completed its business combination with RMG.
